Santen Pharmaceutical Co Stock Market Value
| SNPHF Stock | USD 10.37 0.00 0.00% |
| Symbol | Santen |
Santen Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Santen Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Santen Pharmaceutical.
| 02/26/2024 |
| 05/26/2024 |
If you would invest 0.00 in Santen Pharmaceutical on February 26, 2024 and sell it all today you would earn a total of 0.00 from holding Santen Pharmaceutical Co or generate 0.0% return on investment in Santen Pharmaceutical over 90 days. Santen Pharmaceutical is related to or competes with Sanofi ADR, Bristol Myers, AstraZeneca PLC, Gilead Sciences, and Novartis. Santen Pharmaceutical Co., Ltd. researches and develops, manufactures, and markets pharmaceuticals and medical devices i... More
Santen Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Santen Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Santen Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0101 | |||
| Maximum Drawdown | 12.61 | |||
| Value At Risk | (1.23) | |||
| Potential Upside | 1.39 |
Santen Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Santen Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Santen Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Santen Pharmaceutical historical prices to predict the future Santen Pharmaceutical's volatility.| Risk Adjusted Performance | 0.0308 | |||
| Jensen Alpha | 0.048 | |||
| Total Risk Alpha | (0.04) | |||
| Treynor Ratio | 0.3958 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Santen Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Santen Pharmaceutical Backtested Returns
We consider Santen Pharmaceutical not too volatile. Santen Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0428, which indicates the firm had a 0.0428% return per unit of risk over the last 3 months. We have found nineteen technical indicators for Santen Pharmaceutical Co, which you can use to evaluate the volatility of the company. Please validate Santen Pharmaceutical's Coefficient Of Variation of 2353.68, risk adjusted performance of 0.0308, and Variance of 2.2 to confirm if the risk estimate we provide is consistent with the expected return of 0.064%. Santen Pharmaceutical has a performance score of 3 on a scale of 0 to 100. The entity has a beta of 0.13, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Santen Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Santen Pharmaceutical is expected to be smaller as well. Santen Pharmaceutical right now has a risk of 1.5%. Please validate Santen Pharmaceutical jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Santen Pharmaceutical will be following its existing price patterns.
Auto-correlation | -0.55 |
Good reverse predictability
Santen Pharmaceutical Co has good reverse predictability. Overlapping area represents the amount of predictability between Santen Pharmaceutical time series from 26th of February 2024 to 11th of April 2024 and 11th of April 2024 to 26th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Santen Pharmaceutical price movement. The serial correlation of -0.55 indicates that about 55.0% of current Santen Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.55 | |
| Spearman Rank Test | -0.73 | |
| Residual Average | 0.0 | |
| Price Variance | 0.23 |
Santen Pharmaceutical lagged returns against current returns
Autocorrelation, which is Santen Pharmaceutical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Santen Pharmaceutical's pink sheet expected returns. We can calculate the autocorrelation of Santen Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Santen Pharmaceutical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Santen Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Santen Pharmaceutical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Santen Pharmaceutical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Santen Pharmaceutical pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Santen Pharmaceutical Lagged Returns
When evaluating Santen Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Santen Pharmaceutical pink sheet have on its future price. Santen Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Santen Pharmaceutical autocorrelation shows the relationship between Santen Pharmaceutical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Santen Pharmaceutical Co.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| MSFT | Microsoft | |
| GM | General Motors | |
| CRM | Salesforce | |
| MSFT | Microsoft | |
| GOOG | Alphabet Inc Class C |
Check out Santen Pharmaceutical Correlation, Santen Pharmaceutical Volatility and Santen Pharmaceutical Alpha and Beta module to complement your research on Santen Pharmaceutical. Note that the Santen Pharmaceutical information on this page should be used as a complementary analysis to other Santen Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Santen Pink Sheet analysis
When running Santen Pharmaceutical's price analysis, check to measure Santen Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santen Pharmaceutical is operating at the current time. Most of Santen Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Santen Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santen Pharmaceutical's price. Additionally, you may evaluate how the addition of Santen Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Santen Pharmaceutical technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.